Answer
With Minims Dexamethasone sodium phosphate eye drops, ritonavir or cobicistat may reduce dexamethasone clearance, increasing effects and causing adrenal suppression/Cushing’s syndrome; although unlikely clinically significant after ocular use, avoid combination unless benefits outweigh systemic corticosteroid risks, and monitor for systemic corticosteroid effects if combined.
Sources for this answer
- Minims Dexamethasone sodium phosphate 0.1% w/v, Eye drops solutionBausch & Lomb U.K Limited · emc · SmPC §4.5 Interaction with other medicinal products · Version 10Document updated
Sources checked